Loading...
Serum complement factor I is associated with disease activity of systemic lupus erythematosus
Although aberrant complement activation is involved in the pathogenesis of systemic lupus erythematosus (SLE), the role of complement regulatory proteins in disease activity of SLE remains limited. We enrolled the pediatric-onset SLE patients from our cohort study over 10 years. The clinical and lab...
Saved in:
| Published in: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Impact Journals LLC
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5823600/ https://ncbi.nlm.nih.gov/pubmed/29492211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23907 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|